Antitumoral D-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates

Details for Australian Patent Application No. 2004213148 (hide)

Owner Schering Aktiengesellschaft

Inventors Gege, Christian; Siemeister, Gerhard; Unger, Eberhard; Menzenbach, Bernd; Hillisch, Alexander; Peters, Olaf

Agent Davies Collison Cave

Pub. Number AU-A-2004213148

PCT Pub. Number WO2004/074309

Priority 103 07 103.2 19.02.03 DE

Filing date 19 February 2004

Wipo publication date 2 September 2004

International Classifications

C07J 063/00 Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms

A61P 035/00 Antineoplastic agents

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2004/074309 Priority application(s): WO2004/074309

21 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004213149-Antitumoral 18a-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates

2004213146-2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action